A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe

Published:2020-07-06 Issue:1 Volume:4 Page:
ISSN:2509-8020
Container-title:Journal of Patient-Reported Outcomes
language:en
Short-container-title:J Patient Rep Outcomes

Author:

Ford Janet H.,Foster Shonda A.,Nichols Russell M.,Tockhorn-Heidenreich Antje,Ye Wenyu,Jackson James,Cotton Sarah

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Health Information Management,Health Informatics

Link

http://link.springer.com/content/pdf/10.1186/s41687-020-00221-w.pdf

Reference30 articles.

1. Headache Classification Committee of the International Headache Society. (2018). The international classification of headache disorders, 3rd edition. Cephalalgia, 38(1), 1–211.

2. Burstein, R., Noseda, R., & Borsook, D. (2015). Migraine: Multiple processes, complex pathophysiology. The Journal of Neuroscience, 35(17), 6619–6629. https://doi.org/10.1523/JNEUROSCI.0373-15.2015 .

3. Woldeamanuel, Y. W., & Cowan, R. P. (2017). Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. Journal of the Neurological Sciences, 372, 307–315. https://doi.org/10.1016/j.jns.2016.11.071 .

4. Headache Classification Committee of the International Headache Society. (2013). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia, 33(9), 629–808. https://doi.org/10.1177/0333102413485658 .

5. Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68(5), 343–349. https://doi.org/10.1212/01.wnl.0000252808.97649.21 .

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study;The Journal of Headache and Pain;2024-03-04

2. Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine;Neurology, Neuropsychiatry, Psychosomatics;2024-02-21

3. More Than a Headache: Lived Experience of Migraine in Youth;Pediatric Neurology;2023-09

4. Efficacy of onabotulinumtoxinA Treatment in Episodic Migraine;2023-04-25

5. Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States;Journal of Medical Economics;2023-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3